Cargando…

Cross Talk between Lipid Metabolism and Inflammatory Markers in Patients with Diabetic Retinopathy

Purpose. The purpose of this study was to examine the relationship between metabolic and inflammatory markers in patients with diabetic retinopathy (DR). Methods. 208 adult patients with type 2 diabetes participated in this study and were categorized into (1) mild nonproliferative diabetic retinopat...

Descripción completa

Detalles Bibliográficos
Autores principales: Crosby-Nwaobi, Roxanne, Chatziralli, Irini, Sergentanis, Theodoros, Dew, Tracy, Forbes, Angus, Sivaprasad, Sobha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532932/
https://www.ncbi.nlm.nih.gov/pubmed/26295054
http://dx.doi.org/10.1155/2015/191382
_version_ 1782385275108851712
author Crosby-Nwaobi, Roxanne
Chatziralli, Irini
Sergentanis, Theodoros
Dew, Tracy
Forbes, Angus
Sivaprasad, Sobha
author_facet Crosby-Nwaobi, Roxanne
Chatziralli, Irini
Sergentanis, Theodoros
Dew, Tracy
Forbes, Angus
Sivaprasad, Sobha
author_sort Crosby-Nwaobi, Roxanne
collection PubMed
description Purpose. The purpose of this study was to examine the relationship between metabolic and inflammatory markers in patients with diabetic retinopathy (DR). Methods. 208 adult patients with type 2 diabetes participated in this study and were categorized into (1) mild nonproliferative diabetic retinopathy (NPDR) without clinically significant macular edema (CSME), (2) NPDR with CSME, (3) proliferative diabetic retinopathy (PDR) without CSME, and (4) PDR with CSME. Variable serum metabolic markers were assessed using immunoassays. Multinomial logistic regression analysis was performed. Results. Diabetes duration and hypertension are the most significant risk factors for DR. Serum Apo-B and Apo-B/Apo-A ratio were the most significant metabolic risk factors for PDR and CSME. For every 0.1 g/L increase in Apo-B concentration, the risk of PDR and CSME increased by about 1.20 times. We also found that 10 pg/mL increase in serum TNF-α was associated with approximately 2-fold risk of PDR/CSME while an increase by 100 pg/mL in serum VEGF concentration correlated with CSME. Conclusions. In conclusion, it seems that there is a link between metabolic and inflammatory markers. Apo-B/Apo-A ratio should be evaluated as a reliable risk factor for PDR and CSME, while the role of increased systemic TNF-α and VEGF should be explored in CSME.
format Online
Article
Text
id pubmed-4532932
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-45329322015-08-20 Cross Talk between Lipid Metabolism and Inflammatory Markers in Patients with Diabetic Retinopathy Crosby-Nwaobi, Roxanne Chatziralli, Irini Sergentanis, Theodoros Dew, Tracy Forbes, Angus Sivaprasad, Sobha J Diabetes Res Research Article Purpose. The purpose of this study was to examine the relationship between metabolic and inflammatory markers in patients with diabetic retinopathy (DR). Methods. 208 adult patients with type 2 diabetes participated in this study and were categorized into (1) mild nonproliferative diabetic retinopathy (NPDR) without clinically significant macular edema (CSME), (2) NPDR with CSME, (3) proliferative diabetic retinopathy (PDR) without CSME, and (4) PDR with CSME. Variable serum metabolic markers were assessed using immunoassays. Multinomial logistic regression analysis was performed. Results. Diabetes duration and hypertension are the most significant risk factors for DR. Serum Apo-B and Apo-B/Apo-A ratio were the most significant metabolic risk factors for PDR and CSME. For every 0.1 g/L increase in Apo-B concentration, the risk of PDR and CSME increased by about 1.20 times. We also found that 10 pg/mL increase in serum TNF-α was associated with approximately 2-fold risk of PDR/CSME while an increase by 100 pg/mL in serum VEGF concentration correlated with CSME. Conclusions. In conclusion, it seems that there is a link between metabolic and inflammatory markers. Apo-B/Apo-A ratio should be evaluated as a reliable risk factor for PDR and CSME, while the role of increased systemic TNF-α and VEGF should be explored in CSME. Hindawi Publishing Corporation 2015 2015-07-29 /pmc/articles/PMC4532932/ /pubmed/26295054 http://dx.doi.org/10.1155/2015/191382 Text en Copyright © 2015 Roxanne Crosby-Nwaobi et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Crosby-Nwaobi, Roxanne
Chatziralli, Irini
Sergentanis, Theodoros
Dew, Tracy
Forbes, Angus
Sivaprasad, Sobha
Cross Talk between Lipid Metabolism and Inflammatory Markers in Patients with Diabetic Retinopathy
title Cross Talk between Lipid Metabolism and Inflammatory Markers in Patients with Diabetic Retinopathy
title_full Cross Talk between Lipid Metabolism and Inflammatory Markers in Patients with Diabetic Retinopathy
title_fullStr Cross Talk between Lipid Metabolism and Inflammatory Markers in Patients with Diabetic Retinopathy
title_full_unstemmed Cross Talk between Lipid Metabolism and Inflammatory Markers in Patients with Diabetic Retinopathy
title_short Cross Talk between Lipid Metabolism and Inflammatory Markers in Patients with Diabetic Retinopathy
title_sort cross talk between lipid metabolism and inflammatory markers in patients with diabetic retinopathy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532932/
https://www.ncbi.nlm.nih.gov/pubmed/26295054
http://dx.doi.org/10.1155/2015/191382
work_keys_str_mv AT crosbynwaobiroxanne crosstalkbetweenlipidmetabolismandinflammatorymarkersinpatientswithdiabeticretinopathy
AT chatziralliirini crosstalkbetweenlipidmetabolismandinflammatorymarkersinpatientswithdiabeticretinopathy
AT sergentanistheodoros crosstalkbetweenlipidmetabolismandinflammatorymarkersinpatientswithdiabeticretinopathy
AT dewtracy crosstalkbetweenlipidmetabolismandinflammatorymarkersinpatientswithdiabeticretinopathy
AT forbesangus crosstalkbetweenlipidmetabolismandinflammatorymarkersinpatientswithdiabeticretinopathy
AT sivaprasadsobha crosstalkbetweenlipidmetabolismandinflammatorymarkersinpatientswithdiabeticretinopathy